WallStreetZenWallStreetZen

NASDAQ: BOLT
Bolt Biotherapeutics Inc Stock Ownership - Who owns Bolt Biotherapeutics?

Insider buying vs selling

Have Bolt Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
William P. QuinnChief Financial Officer2023-12-127,500$0.95
$7.13kBuy
Grant YonehiroChief Business Officer2023-12-062,500$0.78
$1.96kBuy
Edith A. PerezChief Medical Officer2023-12-062,500$0.78
$1.96kBuy
William P. QuinnChief Financial Officer2023-12-062,500$0.78
$1.96kBuy
Randall C. SchatzmanChief Executive Officer2023-12-062,500$0.78
$1.96kBuy
Edgar EnglemanDirector2023-11-3014,934$0.86
$12.81kSell
Edgar EnglemanDirector2023-11-30108,145$0.86
$92.79kSell
Edgar EnglemanDirector2023-11-293,131$0.91
$2.84kSell
Edgar EnglemanDirector2023-11-2922,674$0.91
$20.54kSell
Vivo Capital Viii LLC10% Owner2023-11-211,707$0.90
$1.54kSell

1 of 4

BOLT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BOLT insiders and whales buy or sell their stock.

BOLT Shareholders

What type of owners hold Bolt Biotherapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital Viii LLC15.44%5,885,846$7.18MInsider
Holdings A. Novo9.71%3,703,991$4.52MInsider
Tang Capital Management LLC9.58%3,652,244$4.46MInstitution
Vivo Capital LLC9.24%3,521,291$4.30MInstitution
Edgar Engleman8.64%3,293,286$4.02MInsider
Sofinnova Venture Partners X LP7.22%2,754,437$3.36MInsider
Sofinnova Investments Inc7.22%2,754,437$3.36MInstitution
James Healy7.22%2,754,437$3.36MInsider
Citadel Advisors LLC6.45%2,458,958$3.00MInstitution
Pivotal Bioventure Partners Investment Advisor LLC4.96%1,891,467$2.31MInstitution

1 of 3

BOLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLT54.74%45.26%Net Selling
EFTR18.84%81.16%Net Selling
CLNN9.06%52.86%Net Buying
MLEC0.04%9.18%
QTTB47.07%52.93%Net SellingNet Selling

Bolt Biotherapeutics Stock Ownership FAQ

Who owns Bolt Biotherapeutics?

Bolt Biotherapeutics (NASDAQ: BOLT) is owned by 63.28% institutional shareholders, 52.32% Bolt Biotherapeutics insiders, and 0.00% retail investors. Vivo Capital Viii LLC is the largest individual Bolt Biotherapeutics shareholder, owning 5.89M shares representing 15.44% of the company. Vivo Capital Viii LLC's Bolt Biotherapeutics shares are currently valued at $8.24M.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.